Aevice Health Pte. , Ltd.

Aevice Health Pte. Ltd. manufactures the AeviceMD, a medical device classified as a Class II product. Class II devices are generally considered to pose moderate risks and require special controls to ensure their safety and effectiveness, such as performance testing or post-market surveillance. The specific purpose of the AeviceMD aligns with this classification, likely serving a diagnostic, monitoring, or therapeutic function.

Aevice Health Pte. Ltd. is based in the United States. The company’s location is relevant for regulatory compliance, as it operates under the jurisdiction of the U.S. Food and Drug Administration (FDA) for its medical devices.

The AeviceMD device is listed in the FDA’s 510(k) premarket notification process. This registry is used for Class II devices to demonstrate that a new device is substantially equivalent to a legally marketed predicate device, ensuring compliance with FDA requirements before commercial distribution.

The AeviceMD is classified as a Class II device by the FDA. This classification indicates that while the device poses moderate risks, it requires additional controls beyond general controls (like labeling or good manufacturing practices) to ensure its safety and performance. Class II devices often undergo performance testing or other validation processes to meet these requirements.